Literature DB >> 32789722

Intraoperative impedance planimetry (EndoFLIP™) results and development of esophagitis in patients undergoing peroral endoscopic myotomy (POEM).

Mikhail Attaar1,2,3, Bailey Su4,5, Harry J Wong4,5, Kristine Kuchta4, Woody Denham4, Stephen P Haggerty4, John Linn4, Michael B Ujiki4.   

Abstract

INTRODUCTION: Peroral endoscopic myotomy (POEM) is a minimally invasive treatment for achalasia. Considerable evidence demonstrates a high incidence of gastroesophageal reflux disease (GERD) after POEM. The endoluminal functional lumen imaging probe (FLIP) uses impedance planimetry to obtain objective measurements of the gastroesophageal junction. This study aims to determine whether FLIP measurements collected at the time of POEM are associated with the development of reflux esophagitis postoperatively.
METHODS: Patients who underwent POEM between 2012 and 2019 who subsequently had esophagogastroduodenoscopy (EGD) were included. Intraoperative FLIP measurements before and after myotomy, clinical data from EGD, and reflux specific quality of life questionnaires were collected. Comparisons between groups were made using the Wilcoxon rank-sum and Fisher's exact tests. Receiver operating characteristic (ROC) curves were used to determine optimal cutoffs of measurements to classify patients into those with high risk of postoperative esophagitis and those with lower risk.
RESULTS: A total of 43 patients were included. Of those, 25 (58.1%) were found to have esophagitis on postoperative EGD: four patients (16%) with LA Grade A, five (20%) with LA Grade B, 11 (44%) with LA Grade C and two (8%) with LA grade D esophagitis. Patients with a final distensibility index ≥ 2.7 and a final cross-sectional area ≥ 83 were significantly more likely to develop esophagitis on postoperative EGD (p = 0.016 and p = 0.008, respectively). Gastroesophageal reflux disease health-related quality of life (GERD-HRQL) and reflux symptom index (RSI) scores were not significantly different in patients who developed esophagitis and those who did not.
CONCLUSION: Reflux affects some patients after POEM. We show that FLIP measurements collected during POEM may help predict which patients are more likely to develop reflux esophagitis postoperatively. Subjective symptoms on quality of life questionnaires are not reliable in determining which patients are at risk for esophagitis.

Entities:  

Keywords:  Achalasia; EndoFLIP; Esophageal; Impedance planimetry; Peroral endoscopic myotomy (POEM)

Year:  2020        PMID: 32789722     DOI: 10.1007/s00464-020-07876-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  36 in total

1.  A single institution's experience with more than 500 laparoscopic Heller myotomies for achalasia.

Authors:  Alexander S Rosemurgy; Connor A Morton; Melissa Rosas; Michael Albrink; Sharona B Ross
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

2.  Laparoscopic heller myotomy and anterior fundoplication for achalasia results in a high degree of patient satisfaction.

Authors:  M S Yamamura; J C Gilster; B S Myers; C W Deveney; B C Sheppard
Journal:  Arch Surg       Date:  2000-08

3.  Laparoscopic Heller myotomy with Dor fundoplication for achalasia: long-term outcomes and effect on chest pain.

Authors:  A Sasaki; T Obuchi; J Nakajima; Y Kimura; K Koeda; G Wakabayashi
Journal:  Dis Esophagus       Date:  2009-12-11       Impact factor: 3.429

4.  Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial.

Authors:  William O Richards; Alfonso Torquati; Michael D Holzman; Leena Khaitan; Daniel Byrne; Rami Lutfi; Kenneth W Sharp
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

5.  Current clinical approach to achalasia.

Authors:  Alexander J Eckardt; Volker F Eckardt
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

6.  Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience.

Authors:  Giovanni Zaninotto; Mario Costantini; Christian Rizzetto; Lisa Zanatta; Emanuela Guirroli; Giuseppe Portale; Loredana Nicoletti; Francesco Cavallin; Giorgio Battaglia; Alberto Ruol; Ermanno Ancona
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

7.  Ten-year follow-up of laparoscopic Heller myotomy for achalasia shows durability.

Authors:  Louis O Jeansonne; Brent C White; Kelly E Pilger; Matthew D Shane; Stanley Zagorski; S Scott Davis; John G Hunter; Edward Lin; C Daniel Smith
Journal:  Surg Endosc       Date:  2007-07-11       Impact factor: 4.584

8.  Laparoscopic Heller myotomy for achalasia: results after 10 years.

Authors:  Sarah M Cowgill; Desiree Villadolid; Robert Boyle; Sam Al-Saadi; Sharona Ross; Alexander S Rosemurgy
Journal:  Surg Endosc       Date:  2009-06-24       Impact factor: 4.584

9.  Long-term outcomes confirm the superior efficacy of extended Heller myotomy with Toupet fundoplication for achalasia.

Authors:  A S Wright; C W Williams; C A Pellegrini; B K Oelschlager
Journal:  Surg Endosc       Date:  2007-03-01       Impact factor: 3.453

10.  Relief of dysphagia after laparoscopic Heller myotomy improves long-term quality of life.

Authors:  Yassar Youssef; William O Richards; Kenneth Sharp; Michael Holzman; Nikilesh Sekhar; Joan Kaiser; Alfonso Torquati
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

View more
  2 in total

1.  The Predictive Value of Intraoperative Esophageal Functional Luminal Imaging Probe Panometry in Patients With Achalasia Undergoing Peroral Endoscopic Myotomy: A Single-center Experience.

Authors:  Li-Chang Hsing; KyungMin Choi; Kee Wook Jung; Segyeong Joo; Nayoung Kim; Ga Hee Kim; Hee Kyong Na; Ji Yong Ahn; JeongHoon Lee; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

Review 2.  Esophageal Motility Disorders: Current Approach to Diagnostics and Therapeutics.

Authors:  Dhyanesh A Patel; Rena Yadlapati; Michael F Vaezi
Journal:  Gastroenterology       Date:  2022-02-25       Impact factor: 33.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.